Grassi Investment Management Eli Lilly & CO Transaction History

Grassi Investment Management

$1.13 Billion
Q2 2024

A detailed history of Grassi Investment Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Grassi Investment Management holds 79,457 shares of LLY stock, worth $71.7 Million. This represents 6.38% of its overall portfolio holdings.

Number of Shares

79,457

Previous 79,112 0.44%

Holding current value

$71.7 Million

Previous $61.5 Million 16.88%

% of portfolio

6.38%

Previous 5.57%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 09, 2024	BUY	$724.87 - $909.04 $250,080 - $313,618	345 Added 0.44%	79,457 $71.9 Million
Q4 2023 Jan 10, 2024	SELL	$525.19 - $619.13 $157,557 - $185,739	-300 Reduced 0.38%	79,112 $46.1 Million
Q3 2021 Oct 12, 2021	BUY	$221.6 - $272.71 $1,108 - $1,363	5 Added 0.01%	79,412 $18.3 Million
Q2 2021 Jul 09, 2021	SELL	$180.55 - $233.54 $36,110 - $46,708	-200 Reduced 0.25%	79,407 $18.2 Million
Q1 2021 Apr 12, 2021	SELL	$164.32 - $212.72 $53,404 - $69,134	-325 Reduced 0.41%	79,607 $14.9 Million
Q4 2019 Jan 10, 2020	BUY	$106.92 - $132.43 $748 - $927	7 Added 0.01%	79,932 $10.5 Million
Q3 2019 Oct 04, 2019	BUY	$106.79 - $116.16 $13,348 - $14,520	125 Added 0.16%	79,925 $8.94 Million
Q2 2019 Jul 10, 2019	SELL	$110.79 - $129.32 $742,736 - $866,961	-6,704 Reduced 7.75%	79,800 $8.84 Million
Q4 2018 Jan 10, 2019	SELL	$105.9 - $118.64 $47,019 - $52,676	-444 Reduced 0.51%	86,504 $10 Million
Q3 2018 Oct 12, 2018	SELL	$85.86 - $107.31 $119,602 - $149,482	-1,393 Reduced 1.58%	86,948 $9.33 Million
Q2 2018 Jul 10, 2018	SELL	$75.7 - $86.88 $64,269 - $73,761	-849 Reduced 0.95%	88,341 $7.54 Million
Q1 2018 Apr 10, 2018	SELL	$74.21 - $87.6 $81,631 - $96,360	-1,100 Reduced 1.22%	89,190 $6.9 Million
Q4 2017 Jan 10, 2018	SELL	$81.94 - $87.89 $60,799 - $65,214	-742 Reduced 0.82%	90,290 $7.63 Million
Q3 2017 Oct 10, 2017	BUY	$77.07 - $85.54 $7.02 Million - $7.79 Million	91,032	91,032 $7.79 Million

Others Institutions Holding LLY

# of Institutions

3,865

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $858B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Grassi Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Grassi Investment Management with notifications on news.

Account

Grassi Investment Management Eli Lilly & CO Transaction History